Sales Growth YoY (Last 12 Months): Vaccinex, Inc. (VCNX)

Public company logo of Vaccinex Inc (VCNX)

Diversification of research bases guarantees Vaccinex, Inc. (VCNX) process stability, which is critical given geopolitical risks to international trials and patents. The implementation of robotics in antibody discovery further accelerates scientific progress. The YoY sales growth rate over the last four quarters illustrates demand dynamics, where the 1485.40 mark serves as a current indicator of the issuer's market position.

Vaccinex (VCNX) Revenue Growth YoY (Last 12 Months): for the period 02/11/2024 - 02/20/2024

Vaccinex (VCNX) - metric breakdowns and financial figures

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Summary company analytics:Vaccinex, Inc.
Product sample of vaccinex.com

For Vaccinex, Inc. (VCNX), which focuses on the R&D of pepinemab, the year-over-year (YoY) revenue dynamics over a 12-month period serve as an indicator of the pipeline's commercial viability. This metric measures the percentage change in revenue over a rolling year, allowing investors to promptly assess sales stability and the risk of overpaying for the asset prior to the release of official financial statements.

Competitors of Vaccinex, Inc. (VCNX)

Sales Growth YoY (TTM) NantKwest IBRX|IMCR - Sales Growth YoY (Last Twelve Months)|JANX (januxrx.com) - Sales Growth YoY (Last 12 Months)|Arcus Corp (RCUS) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Zymeworks Corp (ZYME)|Revenue Growth YoY (Last 12 Months) TNGX|IOVA - Revenue Growth Rate YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) IMTX (Immatics Corp)|Revenue Change YoY (Last 12 Months) XNCR|Sales Growth YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Revenue Dynamics YoY (Last Twelve Months) REPL|lyell.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Innate Pharma S.A|Pyxis (PYXS) - Sales Growth YoY (Last Twelve Months)|Compugen Ltd - Revenue Dynamics YoY (Last Twelve Months)|IOBT (iobiotech.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) Sutro Biopharma Inc.|Sales Growth YoY (Last Twelve Months) MiNK Therapeutics (INKT)|HOWL: Trailing Twelve Months Sales Growth|Immix Biopharma - Revenue Growth YoY (Last 12 Months)|ALX Oncology (ALXO) - Trailing Twelve Months Revenue Growth|CUE: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth PDSB|sonnetbio.com (SONN) - Sales Growth YoY (Last Twelve Months)|MAIA Biotechnology Inc (MAIA) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) liminatuspharma.com|Sales Growth YoY (Last Twelve Months) LVTX|Revenue Growth YoY (Last 12 Months) NXTC (NextCure, Inc.)|LPTX: Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) intensitytherapeutics.com INTS|Sensei Bio (SNSE) - Trailing Twelve Months Revenue Growth|TOVX: Revenue Growth YoY (Last 12 Months)|Gritstone bio - Revenue Change YoY (Last 12 Months)|Kineta Bio (KA) - Sales Growth YoY (Last Twelve Months)|NexImmune Inc (NEXI) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) Turnstone Biologics Corp.|HARP: Revenue Dynamics YoY (Last Twelve Months)